Search

everythinglearnresearchcommunity

for

Search:↓

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

Long-term opioid use can cause a serious condition where the adrenal glands don't work properly, which doctors should watch out for.

Long-term treatment with buprenorphine/naloxone for opioid addiction may lead to secondary adrenal insufficiency.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Finasteride may help reduce opioid use.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

The conclusion is to thoroughly test for causes of cat hair loss and treat accordingly, considering medication only after serious conditions are ruled out.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Both a lock of hair and a single hair strand can show chronic drug use, but at least six single hairs are needed for accurate results.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Curcumin shows promise for pain relief but needs more research for effective use.

Trichotillomania was successfully treated with risperidone and naltrexone.

Anesthetizing walruses is difficult and risky due to their size and sudden health changes.

Hair analysis can detect drug use but is costly and interpretation is complex.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Neurosteroids may help metyrapone reduce cocaine addiction.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

D'orenone stops root hair growth by disrupting auxin transport, but adding auxin can reverse this.

Morphine increases testosterone breakdown in the rat brain and spinal cord.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Improved delivery systems can enhance oleanolic acid's effectiveness in treating various conditions.

New compounds were made that are promising for prostate cancer therapy.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.